CN104689075B - 治疗压疮的中西药联合的药物 - Google Patents
治疗压疮的中西药联合的药物 Download PDFInfo
- Publication number
- CN104689075B CN104689075B CN201510125823.1A CN201510125823A CN104689075B CN 104689075 B CN104689075 B CN 104689075B CN 201510125823 A CN201510125823 A CN 201510125823A CN 104689075 B CN104689075 B CN 104689075B
- Authority
- CN
- China
- Prior art keywords
- pressure sore
- medicine
- sore
- ratio
- bletilla
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 208000004210 Pressure Ulcer Diseases 0.000 title claims abstract description 84
- 239000003814 drug Substances 0.000 title claims abstract description 84
- 206010011985 Decubitus ulcer Diseases 0.000 title claims abstract description 81
- 229940079593 drug Drugs 0.000 claims abstract description 23
- 241001313855 Bletilla Species 0.000 claims abstract description 22
- 229960003022 amoxicillin Drugs 0.000 claims abstract description 17
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 claims abstract description 17
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 claims abstract description 17
- 241000241413 Propolis Species 0.000 claims abstract description 16
- 229940069949 propolis Drugs 0.000 claims abstract description 16
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims abstract description 14
- 244000247747 Coptis groenlandica Species 0.000 claims abstract description 11
- 235000002991 Coptis groenlandica Nutrition 0.000 claims abstract description 11
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 10
- 240000004824 Trimezia steyermarkii Species 0.000 claims abstract description 10
- 239000009136 dragon's blood Substances 0.000 claims abstract description 10
- 239000000203 mixture Substances 0.000 claims description 13
- 241000245665 Taraxacum Species 0.000 claims description 11
- 229910052602 gypsum Inorganic materials 0.000 claims description 6
- 239000010440 gypsum Substances 0.000 claims description 6
- 206010063560 Excessive granulation tissue Diseases 0.000 abstract description 6
- 210000001126 granulation tissue Anatomy 0.000 abstract description 6
- 230000035876 healing Effects 0.000 abstract description 6
- 240000001949 Taraxacum officinale Species 0.000 abstract description 4
- 208000002193 Pain Diseases 0.000 abstract description 3
- 230000008467 tissue growth Effects 0.000 abstract description 2
- 230000000694 effects Effects 0.000 description 16
- 206010052428 Wound Diseases 0.000 description 13
- 208000027418 Wounds and injury Diseases 0.000 description 13
- 208000025865 Ulcer Diseases 0.000 description 10
- 231100000397 ulcer Toxicity 0.000 description 10
- 239000000126 substance Substances 0.000 description 6
- 230000000202 analgesic effect Effects 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 5
- 241000193830 Bacillus <bacterium> Species 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 229960000723 ampicillin Drugs 0.000 description 4
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 4
- 210000002216 heart Anatomy 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 230000001114 myogenic effect Effects 0.000 description 4
- 230000008520 organization Effects 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 241001478240 Coccus Species 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- 206010053615 Thermal burn Diseases 0.000 description 2
- 208000037386 Typhoid Diseases 0.000 description 2
- 238000004500 asepsis Methods 0.000 description 2
- 230000008952 bacterial invasion Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- YBHILYKTIRIUTE-UHFFFAOYSA-N berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 description 2
- 229940093265 berberine Drugs 0.000 description 2
- QISXPYZVZJBNDM-UHFFFAOYSA-N berberine Natural products COc1ccc2C=C3N(Cc2c1OC)C=Cc4cc5OCOc5cc34 QISXPYZVZJBNDM-UHFFFAOYSA-N 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 230000007123 defense Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000017074 necrotic cell death Effects 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 230000001151 other effect Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000004575 stone Substances 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 201000008297 typhoid fever Diseases 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- QWUWMCYKGHVNAV-UHFFFAOYSA-N 1,2-dihydrostilbene Chemical group C=1C=CC=CC=1CCC1=CC=CC=C1 QWUWMCYKGHVNAV-UHFFFAOYSA-N 0.000 description 1
- CPKVUHPKYQGHMW-UHFFFAOYSA-N 1-ethenylpyrrolidin-2-one;molecular iodine Chemical compound II.C=CN1CCCC1=O CPKVUHPKYQGHMW-UHFFFAOYSA-N 0.000 description 1
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 1
- 241000304886 Bacilli Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- HZZVJAQRINQKSD-UHFFFAOYSA-N Clavulanic acid Natural products OC(=O)C1C(=CCO)OC2CC(=O)N21 HZZVJAQRINQKSD-UHFFFAOYSA-N 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- XDVZNDLANFJOQR-UHFFFAOYSA-N Coptisine Natural products O=Cc1c2OCOc2ccc1C=C3/NCCc4cc5OCOc5cc34 XDVZNDLANFJOQR-UHFFFAOYSA-N 0.000 description 1
- 241000186227 Corynebacterium diphtheriae Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 208000028399 Critical Illness Diseases 0.000 description 1
- 108090000204 Dipeptidase 1 Proteins 0.000 description 1
- FWKBXSPDFCAHFN-UHFFFAOYSA-N Dracorubin Natural products C1CC=2C(OC)=CC=3OC(C=45)=C(C)C(=O)C=C5OC(C=5C=CC=CC=5)=CC=4C=3C=2OC1C1=CC=CC=C1 FWKBXSPDFCAHFN-UHFFFAOYSA-N 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000305071 Enterobacterales Species 0.000 description 1
- 241000194033 Enterococcus Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 241000606768 Haemophilus influenzae Species 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 229920000057 Mannan Polymers 0.000 description 1
- 241000588653 Neisseria Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 241000588770 Proteus mirabilis Species 0.000 description 1
- 206010061926 Purulence Diseases 0.000 description 1
- 206010037714 Quadriplegia Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 241000607768 Shigella Species 0.000 description 1
- 241000607764 Shigella dysenteriae Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 201000005010 Streptococcus pneumonia Diseases 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 208000010513 Stupor Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- LCXREBMNASQAOC-UHFFFAOYSA-N Worenine Chemical compound C1=C2C(C)=C(C=3C(=CC=4OCOC=4C=3)CC3)[N+]3=CC2=CC2=C1OCO2 LCXREBMNASQAOC-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 229940024554 amdinocillin Drugs 0.000 description 1
- 201000004548 amoxicillin allergy Diseases 0.000 description 1
- 230000000629 anti-dermatophyte Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 239000003781 beta lactamase inhibitor Substances 0.000 description 1
- 102000006635 beta-lactamase Human genes 0.000 description 1
- 229940126813 beta-lactamase inhibitor Drugs 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- BWWVAEOLVKTZFQ-ISVUSNJMSA-N chembl530 Chemical compound N(/[C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)=C\N1CCCCCC1 BWWVAEOLVKTZFQ-ISVUSNJMSA-N 0.000 description 1
- 230000002279 cholagogic effect Effects 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- HZZVJAQRINQKSD-PBFISZAISA-N clavulanic acid Chemical compound OC(=O)[C@H]1C(=C/CO)/O[C@@H]2CC(=O)N21 HZZVJAQRINQKSD-PBFISZAISA-N 0.000 description 1
- 229960003324 clavulanic acid Drugs 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- LUXPUVKJHVUJAV-UHFFFAOYSA-M coptisine, chloride Chemical compound [Cl-].C1=C2C=C(C3=C(C=C4OCOC4=C3)CC3)[N+]3=CC2=C2OCOC2=C1 LUXPUVKJHVUJAV-UHFFFAOYSA-M 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000001804 debridement Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- FWKBXSPDFCAHFN-DEOSSOPVSA-N dracorubin Chemical compound C1([C@H]2OC=3C=4C=5C=C(OC6=CC(=O)C(C)=C(C=56)OC=4C=C(C=3CC2)OC)C=2C=CC=CC=2)=CC=CC=C1 FWKBXSPDFCAHFN-DEOSSOPVSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 210000002310 elbow joint Anatomy 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 229940124600 folk medicine Drugs 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229940047650 haemophilus influenzae Drugs 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 210000003692 ilium Anatomy 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 201000002266 mite infestation Diseases 0.000 description 1
- 208000018962 mouth sore Diseases 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 235000019371 penicillin G benzathine Nutrition 0.000 description 1
- 229940056360 penicillin g Drugs 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 210000000954 sacrococcygeal region Anatomy 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 229940007046 shigella dysenteriae Drugs 0.000 description 1
- 230000008470 skin growth Effects 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical class C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 229940126085 β‑Lactamase Inhibitor Drugs 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510125823.1A CN104689075B (zh) | 2015-03-13 | 2015-03-13 | 治疗压疮的中西药联合的药物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510125823.1A CN104689075B (zh) | 2015-03-13 | 2015-03-13 | 治疗压疮的中西药联合的药物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104689075A CN104689075A (zh) | 2015-06-10 |
CN104689075B true CN104689075B (zh) | 2017-12-29 |
Family
ID=53336899
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510125823.1A Active CN104689075B (zh) | 2015-03-13 | 2015-03-13 | 治疗压疮的中西药联合的药物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104689075B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105194154A (zh) * | 2015-10-29 | 2015-12-30 | 李霞 | 一种用于褥疮护理的中西药复方组合物及其制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102688383A (zh) * | 2011-12-21 | 2012-09-26 | 河南科技大学 | 一种用于治疗体表溃疡或溃烂的中药组合物 |
-
2015
- 2015-03-13 CN CN201510125823.1A patent/CN104689075B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102688383A (zh) * | 2011-12-21 | 2012-09-26 | 河南科技大学 | 一种用于治疗体表溃疡或溃烂的中药组合物 |
Non-Patent Citations (3)
Title |
---|
中药血竭调敷治疗压疮研究进展;吴建霞,等;《中国中医药科技》;20111130;第18卷(第6期);第543页右栏最后1段 * |
蜂胶治疗Ⅰ、Ⅱ度压疮的临床效果观察;马虹颖,等;《解放军护理杂志》;20071130;第24卷(第11B期);第75页左栏倒数第3段,右栏第1段 * |
褥疮的辨证施护;贾瑞莲,等;《山西中医》;20020430;第18卷;第88页右栏最后1段,第89页左栏第2段 * |
Also Published As
Publication number | Publication date |
---|---|
CN104689075A (zh) | 2015-06-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105123816A (zh) | 一种检验科用杀菌消毒液及制备方法 | |
CN107029210A (zh) | 雪蛤抗菌肽口腔喷雾剂 | |
CN102526411B (zh) | 一种治疗外科伤口的中药组合物 | |
CN111297961A (zh) | 一种促进伤口愈合的侗药 | |
CN105617316A (zh) | 一种检验科用抑菌消毒液及制备方法 | |
CN104922248A (zh) | 一种抗菌、消炎中药复方凝胶剂及制备方法 | |
CN103239676B (zh) | 一种用于防治细菌性阴道病的外用药物组合物 | |
CN104689075B (zh) | 治疗压疮的中西药联合的药物 | |
CN109602854B (zh) | 一种用于治疗烧烫伤的药膏及其制备方法 | |
CN106038334A (zh) | 含有苦丁茶提取物的抑菌祛味牙膏 | |
CN105902660A (zh) | 一种治疗褥疮、糖尿病足和湿疹的药物组合物 | |
CN101313960A (zh) | 防治青春痘含片 | |
CN102846799A (zh) | 烧烫伤中药外用膏及其制备方法 | |
CN100471518C (zh) | 五虎白冰散 | |
CN103263496B (zh) | 一种用于治疗烧伤的药物组合物 | |
CN106728069B (zh) | 一种治疗烫烧伤的祛腐生肌膏 | |
CN113116968B (zh) | 地榆非药用部位的提取及在抗幽门螺旋杆菌中的应用 | |
CN103638205A (zh) | 一种治疗皮肤病组合物及其制备方法 | |
CN108245577B (zh) | 一种烧伤止痛消肿生肌液膏及其制备方法 | |
CN107137458A (zh) | 一种治疗口腔疾病的维吾尔药组合物破壁制剂及生产方法 | |
CN100438890C (zh) | 一种组织缺损原位再生膏剂 | |
CN108295178B (zh) | 一种用于治疗难愈性创面的中药组合物、中药油膏及其制备方法 | |
CN104887808A (zh) | 一种治疗牙周炎的中药制剂 | |
CN105106475A (zh) | 一种临床护理上用于治疗蕴毒腐溃型褥疮的中药凝胶剂 | |
CN100558376C (zh) | 辣乙素片剂及其制备工艺 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Hao Yumei Inventor after: Hao Wencong Inventor after: Qin Aihua Inventor after: Pang Haiyan Inventor after: Hao Yumei Hao Wencong Qin Aihua Pang Haiyan Hao Yuzhi Zhao Wenjing et Helianzhi Zi Hao Inventor after: Hao Gaofeng Inventor after: Hao Yuzhi Inventor after: Zhao Wenjing Inventor before: Hao Yumei Inventor before: Liu Ruyue Inventor before: Qin Aihua Inventor before: Hao Yuzhi Inventor before: Hao Yumei Liu Ruyue Qin Aihua Hao Yuzhi Zhao Wenjing et Helianzhi Zi Hao Inventor before: Hao Gaofeng Inventor before: Zhao Wenjing |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20191211 Address after: 063000 No.75, caoxiqin East Road, Fengrun District, Tangshan City, Hebei Province Patentee after: Hebei Sanshi Pharmaceutical Co., Ltd Address before: 476100 Shangqiu Medical College, 486 West Beihai Road, Henan, Shangqiu Patentee before: Hao Yumei |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20211111 Address after: 063000 No. 75, Cao Xueqin East Road, Fengrun District, Tangshan City, Hebei Province (304, Sanshi pharmaceutical experimental building) Patentee after: Tangshan Liubai Pharmaceutical Technology Co., Ltd Address before: 063000 No. 75, Cao Xueqin East Road, Fengrun District, Tangshan City, Hebei Province Patentee before: Hebei Sanshi Pharmaceutical Co., Ltd |